New approaches to studying Plasmodium falciparum merozoite invasion and insights into invasion biology

International Journal for Parasitology

Volumn 43, Issue 1, 2013, Pages 1-10

  Boyle, Michelle J ^a   Wilson, Danny W ^b   Beeson, James G ^a,c  

^a BURNET INSTITUTE   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Inhibitors; Invasion; Malaria; Merozoite; Plasmodium falciparum; Vaccines

Indexed keywords

ANTIMALARIAL AGENT; ANTIPYRETIC AGENT; COMPLEMENT; CURDLAN; HEPARIN; HEPARIN DERIVATIVE; IMMUNOGLOBULIN G ANTIBODY; MALARIA VACCINE; MICROORGANISM PROTEIN; PARASITE ANTIBODY;

BIOLOGICAL INVASION; DRUG DEVELOPMENT; INHIBITOR; INVASIVE SPECIES; MALARIA; PROTEIN; PROTOZOAN; SURVIVAL; VACCINE;

ASEXUAL REPRODUCTION; CELLULAR IMMUNITY; DEVELOPMENTAL STAGE; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; DRUG SYNTHESIS; ERYTHROCYTE; HOST PARASITE INTERACTION; HUMAN; HUMORAL IMMUNITY; KINETICS; MALARIA FALCIPARUM; MEDICAL RESEARCH; MEROZOITE; MICROBIAL ACTIVITY; NONHUMAN; PARASITE DEVELOPMENT; PARASITE ISOLATION; PARASITE SURVIVAL; PLASMODIUM FALCIPARUM; PLASMODIUM KNOWLESI; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SURVIVAL TIME; VACCINE PRODUCTION;

ERYTHROCYTES; HUMANS; MEROZOITES; PARASITOLOGY; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM;

EID: 84872393083     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2012.11.002     Document Type: Review

References (105)

1. Adams Y., Freeman C., Schwartz-Albiez R., Ferro V., Parish C.R., Andrews K.T. Inhibition of Plasmodium falciparum growth in vitro and adhesion to chondroitin-4-sulfate by the heparan sulfate mimetic PI-88 and other sulfated oligosaccharides. Antimicrob. Agents Chemother. 2006, 50:2850-2852.
2. Aikawa M., Miller L.H., Johnson J., Rabbege J. Erythrocyte entry by malarial parasites. A moving junction between erythrocyte and parasite. J. Cell Biol. 1978, 77:72-82.
3. Aikawa M., Miller L.H., Rabbege J.R., Epstein N. Freeze-fracture study on the erythrocyte membrane during malarial parasite invasion. J. Cell Biol. 1981, 91:55-62.
4. Angrisano F., Riglar D.T., Sturm A., Volz J.C., Delves M.J., Zuccala E.S., Turnbull L., Dekiwadia C., Olshina M.A., Marapana D.S., Wong W., Mollard V., Bradin C.H., Tonkin C.J., Gunning P.W., Ralph S.A., Whitchurch C.B., Sinden R.E., Cowman A.F., McFadden G.I., Baum J. Spatial localisation of actin filaments across developmental stages of the malaria parasite. PLoS One 2012, 7:e32188.
5. Bannister L.H., Butcher G.A., Dennis E.D., Mitchell G.H. Structure and invasive behaviour of Plasmodium knowlesi merozoites in vitro. Parasitology 1975, 71:483-491.
6. Bannister L.H., Dluzewski A.R. The ultrastructure of red cell invasion in malaria infections: a review. Blood Cells 1990, 16:257-292.
7. Baum J., Richard D., Healer J., Rug M., Krnajski Z., Gilberger T.-W., Green J.L., Holder A.A., Cowman A.F. A conserved molecular motor drives cell invasion and gliding motility across malaria life cycle stages and other apicomplexan parasites. J. Biol. Chem. 2006, 281:5197-5208.
8. Baum J., Chen L., Healer J., Lopaticki S., Boyle M., Triglia T., Ehlgen F., Ralph S.A., Beeson J.G., Cowman A.F. Reticulocyte-binding protein homologue 5 - an essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum. Int. J. Parasitol. 2009, 39:371-380.
9. Beeson J.G., Crabb B.S. Towards a vaccine against Plasmodium vivax malaria. PLoS Med. 2007, 4:e350.
10. Bergmann-Leitner E.S., Duncan E.H., Mullen G.E., Burge J.R., Khan F., Long C.A., Angov E., Lyon J.A. Critical evaluation of different methods for measuring the functional activity of antibodies against malaria blood stage antigens. Am. J. Trop. Med. Hyg. 2006, 75:437-442.
11. Bergmann-Leitner E.S., Duncan E.H., Burge J.R., Spring M., Angov E. Miniaturization of a high-throughput pLDH-based Plasmodium falciparum growth inhibition assay for small volume samples from preclinical and clinical vaccine trials. Am. J. Trop. Med. Hyg. 2008, 78:468-471.
12. Blackman M.J., Ling I.T., Nicholls S.C., Holder A.A. Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Mol. Biochem. Parasitol. 1991, 49:29-33.
13. Blackman M.J. Purification of Plasmodium falciparum merozoites for analysis of the processing of merozoite surface protein-1. Methods Cell Biol. 1994, 45:213-220.
14. Blackman M.J., Dennis E.D., Hirst E.M., Kocken C.H., Scott-Finnigan T.J., Thomas A.W. Plasmodium knowlesi: secondary processing of the malaria merozoite surface protein-1. Exp. Parasitol. 1996, 83:229-239.
15. Bouharoun-Tayoun H., Attanath P., Sabchareon A., Chongsuphajaisiddhi T., Druilhe P. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J. Exp. Med. 1990, 172:1633-1641.
16. Bouharoun-Tayoun H., Druilhe P. Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect. Immun. 1992, 60:1473-1481.
17. Boyle M.J., Richards J.S., Gilson P.R., Chai W., Beeson J.G. Interactions with heparin-like molecules during erythrocyte invasion by Plasmodium falciparum merozoites. Blood 2010, 115:4559-4568.
18. Boyle M.J., Wilson D.W., Richards J.S., Riglar D.T., Tetteh K.K.A., Conway D.J., Ralph S.A., Baum J., Beeson J.G. Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development. Proc. Nat. Acad. Sci. U.S.A. 2010, 107:14378-14383.
19. Brandts C.H., Ndjavé M., Graninger W., Kremsner P.G. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet 1997, 350:704-709.
20. Champion J.A., Katare Y.K., Mitragotri S. Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. J. Control. Release 2007, 121:3-9.
21. Chen L., Lopaticki S., Riglar D.T., Dekiwadia C., Uboldi A.D., Tham W.-H., O'Neill M.T., Richard D., Baum J., Ralph S.A., Cowman A.F. An EGF-like protein forms a complex with PfRh5 and is required for invasion of human erythrocytes by Plasmodium falciparum. PLoS Pathog. 2011, 7:e1002199.
22. Cho S., Kim S., Kim Y., Park Y. Optical imaging techniques for the study of malaria. Trends Biotechnol. 2012, 30:71-79.
23. Clark D.L., Su S., Davidson E.A. Saccharide anions as inhibitors of the malaria parasite. Glycoconjugate J. 1997, 14:473-479.
24. Costa G., Loizon S., Guenot M., Mocan I., Halary F., de Saint-Basile G., Pitard V., Déchanet-Merville J., Moreau J.-F., Troye-Blomberg M., Mercereau-Puijalon O., Behr C. Control of Plasmodium falciparum erythrocytic cycle: γδ T cells target the red blood cell-invasive merozoites. Blood 2011, 118:6952-6962.
25. Cowman A.F., Baldi D.L., Healer J., Mills K.E., O'Donnell R.A., Reed M.B., Triglia T., Wickham M.E., Crabb B.S. Functional analysis of proteins involved in Plasmodium falciparum merozoite invasion of red blood cells. FEBS Lett. 2000, 476:84-88.
26. Crabb B.S., Cowman A.F. Characterization of promoters and stable transfection by homologous and nonhomologous recombination in Plasmodium falciparum. Proc. Nat. Acad. Sci. U.S.A. 1996, 93:7289-7294.
27. Crompton P.D., Miura K., Traore B., Kayentao K., Ongoiba A., Weiss G., Doumbo S., Doumtabe D., Kone Y., Huang C.-Y., Doumbo O.K., Miller L.H., Long C.A., Pierce S.K. In vitro growth-inhibitory activity and malaria risk in a cohort study in mali. Infect. Immun. 2010, 78:737-745.
28. Dennis E.D., Mitchell G.H., Butcher G.A., Cohen S. In vitro isolation of Plasmodium knowlesi merozoites using polycarbonate sieves. Parasitology 1975, 71:475-481.
29. Dent A.E., Bergmann-Leitner E.S., Wilson D.W., Tisch D.J., Kimmel R., Vulule J., Sumba P.O., Beeson J.G., Angov E., Moormann A.M., Kazura J.W. Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adults. PLoS One 2008, 3:e3557.
30. Dondorp A.M. Clinical significance of sequestration in adults with severe malaria. Transfus. Clin. Biol. 2008, 15:56-57.
31. Dondorp A.M., Nosten F., Yi P., Das D., Phyo A.P., Tarning J., Lwin K.M., Ariey F., Hanpithakpong W., Lee S.J., Ringwald P., Silamut K., Imwong M., Chotivanich K., Lim P., Herdman T., An S.S., Yeung S., Singhasivanon P., Day N.P.J., Lindegardh N., Socheat D., White N.J. Artemisinin resistance in Plasmodium falciparum malaria. New Engl. J. Med. 2009, 361:455-467.
32. Duncan C.J.A., Sheehy S.H., Ewer K.J., Douglas A.D., Collins K.A., Halstead F.D., Elias S.C., Lillie P.J., Rausch K., Aebig J., Miura K., Edwards N.J., Poulton I.D., Hunt-Cooke A., Porter D.W., Thompson F.M., Rowland R., Draper S.J., Gilbert S.C., Fay M.P., Long C.A., Zhu D., Wu Y., Martin L.B., Anderson C.F., Lawrie A.M., Hill A.V.S., Ellis R.D. Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/alhydrogel+CPG 7909. PLoS One 2011, 6:e22271.
33. Dvorak J.A., Miller L.H., Whitehouse W.C., Shiroishi T. Invasion of erythrocytes by malaria merozoites. Science 1975, 187:748-750.
34. Dvorin J.D., Martyn D.C., Patel S.D., Grimley J.S., Collins C.R., Hopp C.S., Bright A.T., Westenberger S., Winzeler E., Blackman M.J., Baker D.A., Wandless T.J., Duraisingh M.T. A plant-like kinase in Plasmodium falciparum regulates parasite egress from erythrocytes. Science 2010, 328:910-912.
35. Evans S.G., Morrison D., Kaneko Y., Havlik I. The effect of curdlan sulphate on development in vitro of Plasmodium falciparum. Tran. R. Soc. Trop. Med. Hyg. 1998, 92:87-89.
36. Farrow R.E., Green J., Katsimitsoulia Z., Taylor W.R., Holder A.A., Molloy J.E. The mechanism of erythrocyte invasion by the malarial parasite, Plasmodium falciparum. Sem. Cell. Dev. Biol. 2011, 1-8.
37. Fowkes F.J.I., Richards J.S., Simpson J.A., Beeson J.G. The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: a systematic review and meta-analysis. PLoS Med. 2010, 7:e1000218.
38. Gamo F.J., Sanz L.M., Vidal J., de Cozar C., Alvarez E., Lavandera J.L., Vanderwall D.E., Green D.V., Kumar V., Hasan S., Brown J.R., Peishoff C.E., Cardon L.R., Garcia-Bustos J.F. Thousands of chemical starting points for antimalarial lead identification. Nature 2010, 465:305-310.
39. Gaur D., Mayer D.C.G., Miller L.H. Parasite ligand-host receptor interactions during invasion of erythrocytes by Plasmodium merozoites. Int. J. Parasitol. 2004, 34:1413-1429.
40. Gaur D., Chitnis C.E. Molecular interactions and signaling mechanisms during erythrocyte invasion by malaria parasites. Curr. Opin. Microbiol. 2011, 14:422-428.
41. Gilson P.R., Crabb B.S. Morphology and kinetics of the three distinct phases of red blood cell invasion by Plasmodium falciparum merozoites. Int. J. Parasitol. 2009, 39:91-96.
42. Glushakova S., Yin D., Li T., Zimmerberg J. Membrane transformation during malaria parasite release from human red blood cells. Curr. Biol. 2005, 15:1645-1650.
43. Glushakova S., Humphrey G., Leikina E., Balaban A., Miller J., Zimmerberg J. New stages in the program of malaria parasite egress imaged in normal and sickle erythrocytes. Curr. Biol. 2010, 20:1117-1121.
44. Goel V.K., Li X., Chen H., Liu S.-C., Chishti A.H., Oh S.S. Band 3 is a host receptor binding merozoite surface protein 1 during the Plasmodium falciparum invasion of erythrocytes. Proc. Nat. Acad. Sci. U.S.A. 2003, 100:5164-5169.
45. Grimberg B.T. Methodology and application of flow cytometry for investigation of human malaria parasites. J. Immunol. Methods 2011, 367:1-16.
46. Guiguemde W.A., Shelat A.A., Bouck D., Duffy S., Crowther G.J., Davis P.H., Smithson D.C., Connelly M., Clark J., Zhu F., Jiménez-Díaz M.B., Martinez M.S., Wilson E.B., Tripathi A.K., Gut J., Sharlow E.R., Bathurst I., El Mazouni F., Fowble J.W., Forquer I., Mcginley P.L., Castro S., Angulo-Barturen I., Ferrer S., Rosenthal P.J., Derisi J.L., Sullivan D.J., Lazo J.S., Roos D.S., Riscoe M.K., Phillips M.A., Rathod P.K., van Voorhis W.C., Avery V.M., Guy R.K. Chemical genetics of Plasmodium falciparum. Nature 2010, 465:311-315.
47. Hadley T., Aikawa M., Miller L.H. Plasmodium knowlesi: studies on invasion of rhesus erythrocytes by merozoites in the presence of protease inhibitors. Exp. Parasitol. 1983, 55:306-311.
48. Hanssen E., Goldie K.N., Tilley L. Ultrastructure of the asexual blood stages of Plasmodium falciparum. Methods Cell Biol. 2010, 96:93-116.
49. Hanssen E., McMillan P.J., Tilley L. Cellular architecture of Plasmodium falciparum-infected erythrocytes. Int. J. Parasitol. 2010, 40:1127-1135.
50. Harris P.K., Yeoh S., Dluzewski A.R., O'Donnell R.A., Withers-Martinez C., Hackett F., Bannister L.H., Mitchell G.H., Blackman M.J. Molecular identification of a malaria merozoite surface sheddase. PLoS Pathog. 2005, 1:241-251.
51. Harvey K.L., Gilson P.R., Crabb B.S. A model for the progression of receptor-ligand interactions during erythrocyte invasion by Plasmodium falciparum. Int. J. Parasitol. 2012, 42:567-573.
52. Havlik I., Rovelli S., Kaneko Y. The effect of curdlan sulphate on in vitro growth of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 1994, 88:686-687.
53. Havlik I., Looareesuwan S., Vannaphan S., Wilairatana P., Krudsood S., Thuma P.E., Kozbor D., Watanabe N., Kaneko Y. Curdlan sulphate in human severe/cerebral Plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 2005, 99:333-340.
54. Hodder A.N., Crewther P.E., Anders R.F. Specificity of the protective antibody response to apical membrane antigen 1. Infect. Immun. 2001, 69:3286-3294.
55. John C.C., O'Donnell R.A., Sumba P.O., Moormann A.M., de Koning-Ward T.F., King C.L., Kazura J.W., Crabb B.S. Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein-1 (MSP-1 19) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa. J. Immunol. 2004, 173:666-672. (Baltimore, Md: 1950).
56. Johnson J.G., Epstein N., Shiroishi T., Miller L.H. Factors affecting the ability of isolated Plasmodium knowlesi merozoites to attach to and invade erythrocytes. Parasitology 1980, 80:539-550.
57. Johnson J.G., Epstein N., Shiroishi T., Miller L.H. Identification of surface proteins on viable Plasmodium knowlesi merozoites. J. Protozool. 1981, 28:160-164.
58. Joos C., Marrama L., Polson H.E.J., Corre S., Diatta A.-M., Diouf B., Trape J.-F., Tall A., Longacre S., Perraut R. Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies. PLoS One 2010, 5:e9871.
59. Jouin H., Daher W., Khalife J., Ricard I., Puijalon O.M., Capron M., Dive D. Double staining of Plasmodium falciparum nucleic acids with hydroethidine and thiazole orange for cell cycle stage analysis by flow cytometry. Cytometry Part A J. Int. Soc. Anal. Cytol. 2004, 57:34-38.
60. Kennedy M.C., Wang J., Zhang Y., Miles A.P., Chitsaz F., Saul A., Long C.A., Miller L.H., Stowers A.W. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response. Infect. Immun. 2002, 70:6948-6960.
61. Khattab A., Bonow I., Schreiber N., Petter M., Schmetz C., Klinkert M.-Q. Plasmodium falciparum variant STEVOR antigens are expressed in merozoites and possibly associated with erythrocyte invasion. Malaria J. 2008, 7:137.
62. Kobayashi K., Kato K., Sugi T., Takemae H., Pandey K., Gong H., Tohya Y., Akashi H. Plasmodium falciparum BAEBL binds to heparan sulfate proteoglycans on the human erythrocyte surface. J. Biol. Chem 2010, 285:1716-1725.
63. Kwiatkowski D. Febrile temperatures can synchronize the growth of Plasmodium falciparum in vitro. J. Exp. Med. 1989, 169:357-361.
64. Ladda R., Aikawa M., Sprinz H. Penetration of erythrocytes by merozoites of mammalian and avian malarial parasites. J. Parasitol. 1969, 55:633-644.
65. Langreth S.G., Nguyen-Dinh P., Trager W. Plasmodium falciparum: merozoite invasion in vitro in the presence of chloroquine. Exp. Parasitol. 1978, 46:235-238.
66. Long H.Y., Lell B., Dietz K., Kremsner P.G. Plasmodium falciparum: in vitro growth inhibition by febrile temperatures. Parasitol. Res. 2001, 87:553-555.
67. Macraild C.A., Anders R.F., Foley M., Norton R.S. Apical membrane antigen 1 as an anti-malarial drug target. Curr. Top. Med. Chem. 2011, 11:2039-2047.
68. Marsh K., Otoo L., Hayes R.J., Carson D.C., Greenwood B.M. Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans. R. Soc. Trop. Med. Hyg. 1989, 83:293-303.
69. McCallum F.J., Persson K.E.M., Mugyenyi C.K., Fowkes F.J.I., Simpson J.A., Richards J.S., Williams T.N., Marsh K., Beeson J.G. Acquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum. PLoS One 2008, 3:e3571.
70. McGregor I.A. The passive transfer of human malarial immunity. Am. J. Trop. Med. Hyg. 1964, 13(Suppl.):237-239.
71. Meissner M., Krejany E., Gilson P.R., de Koning-Ward T.F., Soldati D., Crabb B.S. Tetracycline analogue-regulated transgene expression in Plasmodium falciparum blood stages using Toxoplasma gondii transactivators. Proc. Nat. Acad. Sci. U.S.A. 2005, 102:2980-2985.
72. Mitchell G.H., Butcher G.A., Cohen S. A merozoite vaccine effective against Plasmodium knowlesi malaria. Nature 1974, 252:311-313.
73. Mitchell G.H., Thomas A.W., Margos G., Dluzewski A.R., Bannister L.H. Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells. Infect. Immun. 2004, 72:154-158.
74. Moghimi S.M., Hedeman H., Muir I.S., Illum L., Davis S.S. An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen. Biochim. Biophys. Acta 1993, 1157:233-240.
75. Munir M., Tjandra H., Rampengan T.H., Mustadjab I., Wulur F.H. Heparin in the treatment of cerebral malaria. Paediatr. Indones. 1980, 20:47-50.
76. O'Donnell R.A., de Koning-Ward T.F., Burt R.A., Bockarie M., Reeder J.C., Cowman A.F., Crabb B.S. Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria. J. Exp. Med. 2001, 193:1403-1412.
77. O'Donnell R.A., Blackman M.J. The role of malaria merozoite proteases in red blood cell invasion. Curr. Opin. Microbiol. 2005, 8:422-427.
78. Persson K.E.M., Lee C.T., Marsh K., Beeson J.G. Development and optimization of high-throughput methods to measure Plasmodium falciparum-specific growth inhibitory antibodies. J. Clin. Microbiol. 2006, 44:1665-1673.
79. Persson K.E.M., McCallum F.J., Reiling L., Lister N.A., Stubbs J., Cowman A.F., Marsh K., Beeson J.G. Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies. J. Clin. Investig. 2008, 118:342-351.
80. Rampengan T.H. Cerebral malaria in children. Comparative study between heparin, dexamethasone and placebo. Paediatr. Indones. 1991, 31:59-66.
81. Richards J.S., Beeson J.G. The future for blood-stage vaccines against malaria. Immunol. Cell Biol. 2009, 87:377-390.
82. Richard D., Macraild C.A., Riglar D.T., Chan J.-A., Foley M., Baum J., Ralph S.A., Norton R.S., Cowman A.F. Interaction between Plasmodium falciparum apical membrane antigen 1 and the rhoptry neck protein complex defines a key step in the erythrocyte invasion process of malaria parasites. J. Biol. Chem. 2010, 285:14815-14822.
83. Riglar D.T., Richard D., Wilson D.W., Boyle M.J., Dekiwadia C., Turnbull L., Angrisano F., Marapana D.S., Rogers K.L., Whitchurch C.B., Beeson J.G., Cowman A.F., Ralph S.A., Baum J. Super-resolution dissection of coordinated events during malaria parasite invasion of the human erythrocyte. Cell Host Microbe 2011, 9:9-20.
84. Sabchareon A., Burnouf T., Ouattara D., Attanath P., Bouharoun-Tayoun H., Chantavanich P., Foucault C., Chongsuphajaisiddhi T., Druilhe P. Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am. J. Trop. Med. Hyg. 1991, 45:297-308.
85. Saul A., Myler P., Mangan T., Kidson C. Plasmodium falciparum: automated assay of erythrocyte invasion using flow cytofluorometry. Exp. Parasitol. 1982, 54:64-71.
86. Saul A. Kinetic constraints on the development of a malaria vaccine. Parasite Immunol. 1987, 9:1-9.
87. Shi Y.P., Udhayakumar V., Oloo A.J., Nahlen B.L., Lal A.A. Differential effect and interaction of monocytes, hyperimmune sera, and immunoglobulin G on the growth of asexual stage Plasmodium falciparum parasites. Am. J. Trop. Med. Hyg. 1999, 60:135-141.
88. Singh S., Alam M.M., Pal-Bhowmick I., Brzostowski J.A., Chitnis C.E. Distinct external signals trigger sequential release of apical organelles during erythrocyte invasion by malaria parasites. PLoS Pathog. 2010, 6:e1000746.
89. Smitskamp H., Wolthuis F.H. New concepts in treatment of malignant tertian malaria with cerebral involvement. Brit. Med. J 1971, 1:714-716.
90. Spadafora C., Awandare G.A., Kopydlowski K.M., Czege J., Moch J.K., Finberg R.W., Tsokos G.C., Stoute J.A. Complement receptor 1 is a sialic acid-independent erythrocyte receptor of Plasmodium falciparum. PLoS Pathog. 2010, 6:e1000968.
91. Tham W.-H., Wilson D.W., Lopaticki S., Schmidt C.Q., Tetteh-Quarcoo P.B., Barlow P.N., Richard D., Corbin J.E., Beeson J.G., Cowman A.F. Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand. Proc. Nat. Acad. Sci. U.S.A. 2010, 107:17327-17332.
92. Tham W.-H., Schmidt C.Q., Hauhart R.E., Guariento M., Tetteh-Quarcoo P.B., Lopaticki S., Atkinson J.P., Barlow P.N., Cowman A.F. Plasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes. Blood 2011, 118:1923-1933.
93. Thera M.A., Doumbo O.K., Coulibaly D., Laurens M.B., Ouattara A., Kone A.K., Guindo A.B., Traore K., Traore I., Kouriba B., Diallo D.A., Diarra I., Daou M., Dolo A., Tolo Y., Sissoko M.S., Niangaly A., Sissoko M., Takala-Harrison S., Lyke K.E., Wu Y., Blackwelder W.C., Godeaux O., Vekemans J., Dubois M.-C., Ballou W.R., Cohen J., Thompson D., Dube T., Soisson L., Diggs C.L., House B., Lanar D.E., Dutta S., Heppner D.G., Plowe C.V. A field trial to assess a blood-stage malaria vaccine. New Engl. J. Med. 2011, 365:1004-1013.
94. Tonkin C.J., van Dooren G.G., Spurck T.P., Struck N.S., Good R.T., Handman E., Cowman A.F., McFadden G.I. Localization of organellar proteins in Plasmodium falciparum using a novel set of transfection vectors and a new immunofluorescence fixation method. Mol. Biochem. Parasitol. 2004, 137:13-21.
95. Treeck M., Zacherl S., Herrmann S., Cabrera A., Kono M., Struck N.S., Engelberg K., Haase S., Frischknecht F., Miura K., Spielmann T., Gilberger T.W. Functional analysis of the leading malaria vaccine candidate AMA-1 reveals an essential role for the cytoplasmic domain in the invasion process. PLoS Pathog. 2009, 5:e1000322.
96. Triglia T., Chen L., Lopaticki S., Dekiwadia C., Riglar D.T., Hodder A.N., Ralph S.A., Baum J., Cowman A.F. Plasmodium falciparum merozoite invasion is inhibited by antibodies that target the PfRh2a and b binding domains. PLoS Pathog. 2011, 7:e1002075.
97. van Dijk M.R., Waters A.P., Janse C.J. Stable transfection of malaria parasite blood stages. Science 1995, 268:1358-1362.
98. Vogt A.M., Pettersson F., Moll K., Jonsson C., Normark J., Ribacke U., Egwang T.G., Ekre H.-P., Spillmann D., Chen Q., Wahlgren M. Release of sequestered malaria parasites upon injection of a glycosaminoglycan. PLoS Pathog. 2006, 2:e100.
99. Wegscheid-Gerlach C., Gerber H.-D., Diederich W.E. Proteases of Plasmodium falciparum as potential drug targets and inhibitors thereof. Curr. Top. Med. Chem. 2010, 10:346-367.
100. Wilson D.W., Crabb B.S., Beeson J.G. Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays. Malaria J. 2010, 9:152.
101. Wilson D.W., Fowkes F.J.I., Gilson P.R., Elliott S.R., Tavul L., Michon P., Dabod E., Siba P.M., Mueller I., Crabb B.S., Beeson J.G. Quantifying the importance of MSP1-19 as a target of growth-inhibitory and protective antibodies against Plasmodium falciparum in humans. PLoS One 2011, 6:e27705.
102. Wong W., Skau C.T., Marapana D.S., Hanssen E., Taylor N.L., Riglar D.T., Zuccala E.S., Angrisano F., Lewis H., Catimel B., Clarke O.B., Kershaw N.J., Perugini M.A., Kovar D.R., JGulbis M., Baum J. Minimal requirements for actin filament disassembly revealed by structural analysis of malaria parasite actin-depolymerizing factor 1. Proc. Nat. Acad. Sci. U.S.A. 2011, 108:9869-9874.
103. World Health Organization Global Malaria Programme World Malaria Report 2010 2010, WHO, Geneva.
104. World Health Organization Guidelines for the Treatment of Malaria 2010, WHO, Geneva.
105. Yu L., Garg H.G., Li B., Linhardt R.J., Hales C.A. Antitumor effect of butanoylated heparin with low anticoagulant activity on lung cancer growth in mice and rats. Curr. Cancer Drug Targets 2010, 10:229-241.